United States

Showing 181-190 of 355 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
University of Michigan and OHSU Breakthrough T1D Cardio-Renal Center of Excellence : Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications for People with T1D	Regents of the University of Michigan	Matthias Kretzler	Improving Lives	01-May-2025 to 30-April-2028	$2.842.434,27
GeLite: Glowing Engineered Luminescent Microgels for Transplant Evaluation	Regents of the University of Michigan	Maria Coronel	Cures	01-June-2024 to 31-October-2026	$200.000,00
Longitudinal non-inasive monitoring of vascular remodeling using oxygen-sensing nanoprobes	Regents of the University of Michigan	Maria Coronel	Cures	01-March-2025 to 28-February-2030	$1.000.000,00
Identifying pharmaceuticals for enhancing metabolic maturity of stem cell derived islets	Regents of the University of Michigan	Lonnie Shea	Cures	01-December-2024 to 30-November-2027	$1.125.000,00
Electrochemiluminescence-based islet autoantibody assays detect the islet autoimmunity earlier and more disease specific than radio-binding assay in the longitudinally followed new-born cohort of TEDDY study	Regents of the University of Colorado	Xiaofan Jia	Cures	01-June-2025 to 31-May-2027	$499.989,00
Continuous Ketone Monitoring as a Tool to Identify Hyperglycemic Events and Predict Kidney Disease Progression in Individuals with Type 1 Diabetes and Moderate-to-Severe Diabetic Kidney Disease	Regents of the University of Colorado	Sarit Polsky	Improving Lives	01-September-2026 to 31-August-2029	$1.400.119,27
Testing the role of the PI3K-AKT-FOXO1-CXCR4 pathway in the bone marrow selection of anti-insulin B cells in T1D	Regents of the University of Colorado	Roberta Pelanda	Cures	01-November-2023 to 31-October-2027	$826.284,00
Contrast enhanced ultrasound imaging to track type 1 diabetes progression in at-risk pediatric subjects	Regents of the University of Colorado	Richard Benninger	Cures	01-August-2026 to 31-July-2029	$707.121,00
Targeting sub-micron ultrasound contrast agents to the immune-infiltrated islet microenvironment in Type1 diabetes	Regents of the University of Colorado	Richard Benninger	Cures	01-July-2024 to 30-June-2027	$900.000,00
Improving the Uptake and Applicability of the Clinical and Economic Optimization Platform for Type 1 Diabetes Screening	Regents of the University of Colorado	R. Brett McQueen	Cures	01-September-2024 to 31-August-2027	$451.890,07